(Q73321469)
Statements
Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer (English)
F Içli
H Karaoguz
H Akbulut
D Dinçol
A Demirkazik
scientific article published on 01 April 1997